About nanoappsmedical

NanoApps Medical - Official website

Tricking the novel coronavirus with a fake ‘handshake’

Scientists have developed protein fragments—called peptides—that fit snugly into a groove on the SARS-CoV-2 Spike protein that it would normally use to access a host cell. These peptides effectively trick the virus into "shaking hands" with a replica rather than with the actual protein on a cell's surface that lets the virus in. Previous research has determined that the novel coronavirus [...]

By |2021-02-24T13:20:48+00:00February 24th, 2021|Categories: News|0 Comments

Researchers reveal genetic predisposition to severe COVID-19

HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology. T-cell immunity is one of the key mechanisms used by the human body to fight virus infections. The staging ground for cell immunity development is [...]

By |2021-02-23T15:17:34+00:00February 23rd, 2021|Categories: News|0 Comments

What Pseudoviruses Bring to the Study of SARS-CoV-2

When SARS-CoV-2 first began spreading across the globe, not every lab was equipped to study it directly. The virus behind the current pandemic is highly pathogenic and transmissible, leading the US Centers for Disease Control and Prevention to require many of the same biosafety guidelines that shape the study of diseases such as tuberculosis and Ebola. [...]

By |2021-02-22T07:51:40+00:00February 22nd, 2021|Categories: News|0 Comments

Covid-19: Future targets for treatments rapidly identified with new computer simulations

esearchers have detailed a mechanism in the distinctive corona of Covid-19 that could help scientists to rapidly find new treatments for the virus, and quickly test whether existing treatments are likely to work with mutated versions as they develop. The team, led by the University of Warwick as part of the EUTOPIA community of [...]

By |2021-02-21T10:56:41+00:00February 21st, 2021|Categories: News|0 Comments

Almost Half of Coronavirus Sufferers Report Depression

Almost half of people testing positive for coronavirus have reported symptoms of depression, according to a new study published in the International Journal of Environmental Research and Public Health. Researchers from Bangladesh, the United States and Anglia Ruskin University (ARU) in the UK carried out a cross-sectional survey of more than 1,000 Bangladeshi adult coronavirus [...]

By |2021-02-18T06:31:43+00:00February 18th, 2021|Categories: News|0 Comments

Six previously FDA-approved drugs appear promising against SARS-CoV-2 in laboratory testing

A team of investigators from the Republic of China has discovered that 6 drugs previously approved by the US Food and Drug Administration (FDA) for other indications could be repurposed to treat or prevent COVID-19. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology. Using FDA-approved drugs [...]

By |2021-02-18T06:20:35+00:00February 18th, 2021|Categories: News|0 Comments

Graphene could one day be used to make quick, reliable tests for viruses like SARS-CoV-2

Graphene is a layer of carbon only one atom thick. Since it was first isolated in 2004, it has found applications in strengthening materials, accelerating electronics, and boosting performance in batteries, among others. It also shows great potential for use in biosensors. These are devices used to detect small concentrations of biomarkers in biological [...]

By |2021-02-17T08:56:59+00:00February 17th, 2021|Categories: News|0 Comments

UK spots 33 cases of ANOTHER Covid variant

Another Covid variant that could dodge vaccine-triggered immunity has been identified in the UK, scientists say. The strain — called B.1.525 — has been spotted 33 times already but experts say this could be an underestimate. It carries the E484K mutation found on both the South African and Brazilian variants, which make the current [...]

By |2021-02-16T12:06:16+00:00February 16th, 2021|Categories: News|0 Comments

Spotlight on mRNA vaccines: Covid-19 approvals highlight a novel competitive landscape in oncology

The ongoing Covid-19 pandemic has yielded an unexpected advancement in the pharmaceutical industry with the approval of the first mRNA vaccines, which GlobalData expects will soon impact other indications. This historical landmark could have significant implications, primarily in the oncology market since mRNA vaccines were being exclusively investigated in infectious and oncology diseases prior [...]

By |2021-02-15T13:49:44+00:00February 10th, 2021|Categories: News|0 Comments

New AI Tool Can Thwart Coronavirus Mutations

USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy. Using artificial intelligence (AI), the research team at the USC Viterbi School of Engineering developed a method to speed the analysis of [...]

By |2021-02-07T16:49:18+00:00February 7th, 2021|Categories: News|0 Comments